Previous close | 21.25 |
Open | 21.21 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 21.08 - 21.28 |
52-week range | 17.19 - 30.14 |
Volume | |
Avg. volume | 722,061 |
Market cap | 2.243B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 24.52 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Here are 5 biggest share buyback announcements from the past week you may have missed on InvestingPro. Verisk Analytics (NASDAQ:VRSK) announced that it has entered into accelerated share repurchase agreements with each of Citibank, and Goldman Sachs to repurchase an aggregate of $2.5B of the company's common stock. Morgan Stanley said on Thursday it's adding a position to the company, given (1) industry-standard network effects in an attractive industry, (2) attractive valuation after the company’s return to its traditional property and casualty-focused end markets after selling non-core business segments, and (3) from a portfolio perspective, reduces the Model’s volatility and exposure to consumer discretionary while adding exposure to high-quality industrials.
Corcept Therapeutics ( NASDAQ:CORT ) Full Year 2022 Results Key Financial Results Revenue: US$401.9m (up 9.8% from FY...
Corcept Therapeutics' (CORT) fourth-quarter earnings and revenues lag estimates.